Value stocks haven't done well in the era of easy money, with cash piling into growth names. But, that could be about to change.
Pfizer's CEO Ian Read could make almost $28 million in the next year to keep him from retiring. Strangely enough, he may earn it given the healthcare and political environment.
Sensing an opportunity, investors raced to eat up several big-cap stocks in February. Here are the biggest buys.
Jim Cramer takes a look at Square, Manitowoc, Valley National Bancorp, FMC Corp., Universal Display, CIT Group, Oneok, and Albemarle.